Klin Farmakol Farm. 2022;36(1):4-7 | DOI: 10.36290/far.2022.001

Determination of ampicillin plasma concentrations in single-dose administration for cardiac surgery prophylaxis

Vendula Kubíčková1, Petr Šantavý2, Karel Urbánek1
1 Ústav farmakologie LF UP a FN Olomouc
2 Kardiochirurgická klinika LF UP a FN Olomouc

The aim of this study was to determine the plasma concentration of ampicillin in plasma of patients undergoing myocardial revascularization without extracorporeal circulation and to calculate its basic pharmacokinetic parameters. An HPLC method with UV detection and Luna® Omega Polar C18 Column (250 × 4 mm; 5 µm) utilization was introduced and validated to determine ampicillin concentration. Individual pharmacokinetic parameters were calculated in MW Pharm 3.30 using a one-compartment model. Plasma concentrations of ampicillin were measured in 20 patients at 15, 30, 45, 60, 120, and 180 min after administration and at the end of surgery. Mean Cmax was found to be 127 ± 49 mg/l, elimination half-life 77 ± 29 min, total clearance 191 ± 73 ml/min, and distribution volume 19 ± 4 l. The calculated mean time for the plasma concentration of ampicillin to decrease to the predicted threshold of efficacy (mg/l) was 8.5 ± 3.5 h.

Keywords: ampicillin, prophylaxis, cardiac surgery, plasma concentrations.

Published: May 5, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kubíčková V, Šantavý P, Urbánek K. Determination of ampicillin plasma concentrations in single-dose administration for cardiac surgery prophylaxis. Klin Farmakol Farm. 2022;36(1):4-7. doi: 10.36290/far.2022.001.
Download citation

References

  1. Onita T, Ikawa K, Nakamura K, Nishikawa G, Kobayashi I, Ishihara N, Tamaki H, Yano T, Naora K, Morikawa N. Prostatic Pharmacokinetic/Pharmacodynamic Evaluation of Ampicillin-Sulbactam for Bacterial Prostatitis and Preoperative Prophylaxis. J Clin Pharmacol. 2021;61:820-831. Go to original source... Go to PubMed...
  2. Mai XL, Phamb TV, Han GH, Kum SJ, Woo SH, Kang JS, Woo MH, Na DH, Chun IK, Kim KH. Simultaneous determination of ampicillin sodium and sulbactam sodium in powder for injection by HPLC. Anal Sci Technol. 2019;32:147-154.
  3. SPC Unasyn, Summary of Product Characteristics: https:// www.sukl.cz/modules/medication/detail.php?kod =0016600(accessed on Oct. 05, 2021).
  4. Grayson ML, Cosgrove S, Crowe SM et al. Kucers' the use of antibiotics: A clinical review of antibacterial, antifungal, anti­parasitic, and antiviral drugs, seventh edition. Boca Raton: CRC Press, 2018. ISBN 9781498747950. Go to original source...
  5. Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg. 2007;83(4):1569-1576. Go to original source... Go to PubMed...
  6. do Nascimento TG, Aragao CFS, de Medeiros FD, Oliveira ED, Macedo RO. Validation of a method for determination of ampicillin in human plasma using LC-DAD. J Chrom Sci. 2009;47:749-755. Go to original source... Go to PubMed...
  7. Peng L, Wang X, Dang H. Simultaneous determination of meropenem and imipenem in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr. 2021;35(11):e5185. Go to original source... Go to PubMed...
  8. Wildfeuer A, Müller V, Springsklee M, Sonntag HG. Pharma­co­kinetics of ampicillin and sulbactam in patients undergoing heart­ surgery. Antimicrob Agents Chemother. 1991;35(9):1772-1776. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.